LivaNova PLC (NASDAQ:LIVN) Given Average Recommendation of "Buy" by Analysts

Key Points

• LivaNova PLC (NASDAQ:LIVN) has received an average recommendation of "Buy" from analysts, with one strong buy, six buy, and one hold ratings assigned by eight brokerages.
• The company's average 12-month price target from analysts is $59.29, with notable upgrades leading to targets as high as $64.00.
• LivaNova reported a 10.6% year-over-year increase in revenue for the last quarter, totaling $352.50 million, and exceeded earnings expectations by reporting an EPS of $1.05.

LivaNova PLC (NASDAQ:LIVN - Get Free Report) has received an average recommendation of "Buy" from the eight research firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $59.2857.

Several research firms have weighed in on LIVN. Barclays lowered their price target on LivaNova from $56.00 to $55.00 and set an "equal weight" rating on the stock in a research report on Thursday, May 8th. Wolfe Research raised LivaNova from a "peer perform" rating to an "outperform" rating and set a $60.00 target price on the stock in a report on Tuesday, May 20th. Robert W. Baird boosted their target price on LivaNova from $55.00 to $61.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. Wall Street Zen raised LivaNova from a "buy" rating to a "strong-buy" rating in a report on Saturday. Finally, Needham & Company LLC reissued a "buy" rating and set a $64.00 target price on shares of LivaNova in a report on Tuesday, May 13th.

LivaNova Stock Up 3.5%

NASDAQ LIVN traded up $1.79 during trading on Friday, hitting $52.43. The stock had a trading volume of 374,689 shares, compared to its average volume of 707,932. The company has a market capitalization of $2.86 billion, a PE ratio of -13.50 and a beta of 0.92. The company's 50-day moving average price is $45.19 and its two-hundred day moving average price is $42.80. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.09 and a current ratio of 1.29. LivaNova has a 12 month low of $32.48 and a 12 month high of $57.35.

LivaNova (NASDAQ:LIVN - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $1.05 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.21. The firm had revenue of $352.50 million for the quarter, compared to analyst estimates of $332.20 million. LivaNova had a positive return on equity of 14.57% and a negative net margin of 16.13%. The business's quarterly revenue was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.93 EPS. As a group, sell-side analysts forecast that LivaNova will post 2.85 EPS for the current year.

Institutional Trading of LivaNova

Institutional investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC boosted its stake in LivaNova by 182.5% in the 2nd quarter. GAMMA Investing LLC now owns 630 shares of the company's stock valued at $28,000 after purchasing an additional 407 shares during the period. UMB Bank n.a. boosted its stake in LivaNova by 340.5% in the 1st quarter. UMB Bank n.a. now owns 837 shares of the company's stock valued at $33,000 after purchasing an additional 647 shares during the period. CWM LLC boosted its stake in LivaNova by 52.3% in the 1st quarter. CWM LLC now owns 871 shares of the company's stock valued at $34,000 after purchasing an additional 299 shares during the period. Parallel Advisors LLC boosted its stake in LivaNova by 1,312.3% in the 2nd quarter. Parallel Advisors LLC now owns 1,031 shares of the company's stock valued at $46,000 after purchasing an additional 958 shares during the period. Finally, Caitong International Asset Management Co. Ltd boosted its stake in LivaNova by 415.4% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,469 shares of the company's stock valued at $58,000 after purchasing an additional 1,184 shares during the period. 97.64% of the stock is currently owned by institutional investors.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.